NEW YORK (Reuters Health) - The safety of a popular drug for seizures took another hit Wednesday when researchers pinned a handful of major birth defects on the medication.
NEW YORK (Reuters Health) - The safety of a popular drug for seizures took another hit Wednesday when researchers pinned a handful of major birth defects on the medication.